Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer based in Jerusalem, Israel, covers the month of August 2019. The report, dated August 5, 2019, consists solely of a press release issued on that date, which is attached as Exhibit 99.1 and incorporated by reference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As this report incorporates only a press release, it does not contain audited financial statements or detailed financial data tables.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document serves as a vehicle to distribute a press release rather than a financial performance report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The content of the referenced press release is not included in the provided text, preventing a summary of these qualitative factors.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K incorporating a press release dated August 5, 2019.
- No financial data (revenue, cash, debt) is present in the provided text.
- Investors must review the attached Exhibit 99.1 (the press release) to understand the specific corporate announcement triggering this filing.
- The registrant files annual reports under Form 20-F.